1-(beta-D-Ribofuranosyl)-2-thioxo-2,3-dihydro-4(1H)-pyrimidinone(CAS: 20235-78-3)

This compound is regulated under the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) as a category 1A mutagen. It is also subject to the European Union’s REACH regulations, which require registration for substances above certain tonnage thresholds. FDA and EPA may also have specific labeling and handling requirements for this compound, particularly in pharmaceutical and environmental contexts.

Several alternatives can be used in the synthesis of this compound, such as 1-(beta-D-Ribofuranosyl)-2-thiohydantoin, which serves as a similar structural analog. Common alternative reagents include 2-thiouracil and other pyrimidine derivatives.

Research trends indicate increasing interest in this compound due to its potential use as a mutagenic agent in genetic studies. Market trends highlight a growing demand in pharmaceutical and biotech industries for mutagenic compounds to study DNA repair mechanisms and enzyme interactions.

Waste containing this compound should be collected in appropriate containers and disposed of through professional waste disposal services, as it is a regulated mutagen. Incineration is recommended for safe disposal, provided it meets environmental and safety standards. Proper environmental protection precautions, such as adequate ventilation and protective equipment, must be observed during handling and disposal.